Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07541469 · ClinicalTrials.gov registry record
Rezdiffra Pregnancy and Lactation Registry
A clinical trial, sponsored by Madrigal Pharmaceuticals.
- Recruiting
- Registry status
- 10
- Enrollment target
NCT07541469 is a clinical trial that is actively recruiting participants, run by Madrigal Pharmaceuticals. The registered enrollment target is 10 participants.
The verdict
NCT07541469 is actively recruiting participants, sponsored by Madrigal Pharmaceuticals.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
To evaluate pregnancy and clinical outcomes in women with NASH and their infants after exposure to Rezdiffra at any time during pregnancy and/or lactation.
Interventions
- DRUG Rezdiffra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-03-04 |
| Est. Completion | 2030-04-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07541469
The ClinicalTrials.gov registry entry for NCT07541469 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Madrigal Pharmaceuticals, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rezdiffra is the first listed.
NCT07541469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07541469 about?
NCT07541469 is a clinical study titled "Rezdiffra Pregnancy and Lactation Registry". To evaluate pregnancy and clinical outcomes in women with NASH and their infants after exposure to Rezdiffra at any time during pregnancy and/or lactation.
What is the current status of trial NCT07541469?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2026-03-04. Estimated completion is 2030-04-08.
What interventions are being tested in trial NCT07541469?
The interventions under investigation include: Rezdiffra (DRUG).
Who is sponsoring clinical trial NCT07541469?
This trial is sponsored by Madrigal Pharmaceuticals, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.